Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLN9708, Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma
NCT01936532Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Nov 2014
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM), sponsored by CHU de Nantes. Started Nov 2014; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01936532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936532.